Selected research
-
High Retention and Adherence with Rapid Long-Acting Injectable PrEP Implementation in an Urban Safety-Net Clinic Population.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
-
Preexposure Prophylaxis (PrEP) for HIV.
JAMA
-
48-week viral suppression rates in people with HIV starting long-acting CAB/RPV with initial viremia.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America